KK
PLRX icon

Kotler Kevin’s Pliant Therapeutics PLRX Stock Holding History

Kotler Kevin’s Portfolio PLRX Stock Details PLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$113K Buy
+93,000
New +$140K 0.03% 38

Other funds holding PLRX

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $665M AUM 95.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $1.26B AUM 60.23% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return

Kotler Kevin's PLRX Position: Q4 2025 in Review

Kotler Kevin opened a new position in Pliant Therapeutics (PLRX) in Q4 2025: 93,000 shares worth $113K. The stake represents 0.03% of the portfolio and ranks #38 among its holdings.

96 funds tracked by Wall St. Rank hold PLRX as of Q4 2025.

  • Kotler Kevin held 93,000 shares of Pliant Therapeutics worth $113K as of Q4 2025.
  • Pliant Therapeutics was a new Kotler Kevin position in Q4 2025.
  • Pliant Therapeutics made up 0.03% of Kotler Kevin's portfolio in Q4 2025, its #38 holding.
  • 96 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q4 2025.

Based on Kotler Kevin's 13F filing for Q4 2025, filed 17 Feb 2026.